JR
Reny, Jean-Luc
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Overweight and obesity association with mortality in patients with heart failure and reduced or preserved ejection fraction-a cohort study | PloS one | 2026 | 26 | 91 | |||
| Relevance and limitations of clinical follow-up in a pharmacokinetic study on direct oral anticoagulants | Frontiers in pharmacology | 2026 | 4 | 7 | |||
| MicroRNA-223-3p is a determinant of platelet procoagulant activity | Blood advances | 2026 | 17 | 47 | |||
| Impact of care reorganisation during COVID-19 waves on non-COVID-19 inpatients in a Swiss hospital : a retrospective cohort study | Swiss medical weekly | 2026 | 1 | 0 | |||
| Cytochrome P450 phenotyping using the Geneva cocktail improves metabolic capacity prediction in a hospitalized patient population | British journal of clinical pharmacology | 2025 | 45 | 0 | |||
| Inflammatory predictors of Post-COVID fatigue | Brain, behavior, & immunity. Health | 2025 | 3 | 6 | |||
| Improving Understanding of Fexofenadine Pharmacokinetics to Assess Pgp Phenotypic Activity in Older Adult Patients Using Population Pharmacokinetic Modeling | Clinical pharmacokinetics | 2025 | 66 | 108 | |||
| Impact de la réorganisation des soins pendant les vagues de COVID-19 sur les patients hospitalisés pour un autre diagnostic que le COVID : étude de cohorte rétrospective monocentrique | 90e Congrès Français de Médecine Interne | 2025 | 50 | 0 | |||
| Virtual twin approach using physiologically based pharmacokinetic modelling in hospitalized patients treated with apixaban or rivaroxaban | British journal of clinical pharmacology | 2025 | 80 | 0 | |||
| Systemic cytokines related to memory function 6-9 months and 12-15 months after SARS-CoV-2 infection | Scientific reports | 2024 | 61 | 152 | |||
| Monitoring low-value care in medical patients from Swiss university hospitals using a Findable, Accessible, Interoperable, Reusable (FAIR) national data stream and patient and public involvement : LUCID study protocol | BMJ open | 2024 | 63 | 156 | |||
| Persistence and emergence of new neuropsychological deficits following SARS-CoV-2 infection : A follow-up assessment of the Geneva COVID-COG cohort | Journal of global health | 2024 | 125 | 140 | |||
| Protocol for a multicentric, double-blind, randomised controlled trial of hyperbaric oxygen therapy (HBOT) versus sham for treating vaso-occlusive crisis (VOC) in sickle cell disease (SCD) in patients aged 8 years or older (HBOT-SCD study) | BMJ open | 2024 | 106 | 217 | |||
| Frequency of Abnormally Low Neuropsychological Scores in Post-COVID-19 Syndrome: the Geneva COVID-COG Cohort | Archives of clinical neuropsychology | 2023 | 496 | 419 | |||
| Brain functional connectivity alterations associated with neuropsychological performance 6–9 months following SARS‐CoV ‐2 infection | Human brain mapping | 2023 | 279 | 160 | |||
| Acute TNFα levels predict cognitive impairment 6-9 months after COVID-19 infection | Psychoneuroendocrinology | 2023 | 205 | 151 | |||
| Use of complementary medicine and its association with SARS-CoV-2 vaccination during the COVID-19 pandemic : a longitudinal cohort study | Swiss medical weekly | 2023 | 62 | 149 | |||
| Markers of limbic system damage following SARS-CoV-2 infection | Brain communications | 2023 | 270 | 114 | |||
| Apixaban and rivaroxaban's physiologically-based pharmacokinetic model validation in hospitalized patients: A first step for larger use of a priori modeling approach at bed side | CPT: pharmacometrics & systems pharmacology | 2023 | 146 | 436 | |||
| The longitudinal study of subjective wellbeing and absenteeism of healthcare workers considering post-COVID condition and the COVID-19 pandemic toll | Scientific reports | 2023 | 153 | 39 | |||
| Trends in management and outcomes of COVID patients admitted to a Swiss tertiary care hospital | Scientific reports | 2023 | 207 | 128 | |||
| Enoxaparin versus placebo to prevent symptomatic venous thromboembolism in hospitalized older adult medical patients | NEJM evidence | 2023 | 104 | 0 | |||
| Prevalence of Post-COVID Condition 12 Weeks After Omicron Infection Compared With Negative Controls and Association With Vaccination Status | Clinical infectious diseases | 2023 | 170 | 240 | |||
| Population pharmacokinetics of apixaban in a real-life hospitalized population from the OptimAT study | CPT: pharmacometrics & systems pharmacology | 2023 | 133 | 396 | |||
| PCSK9 inhibitors and ezetimibe for the reduction of cardiovascular events: a clinical practice guideline with risk-stratified recommendations | BMJ | 2022 | 27 | 0 | |||
| Accuracy of a score predicting the presence of an atypical pathogen in hospitalized patients with moderately severe community-acquired pneumonia | BMC infectious diseases | 2022 | 85 | 174 | |||
| A bilateral aseptic pyogenic ventriculitis following a course of pembrolizumab, an anti-PD-1 immune checkpoint inhibitor treatment for metastatic small cell lung cancer | Thérapie | 2022 | 56 | 0 | |||
| One-year persistent symptoms and functional impairment in SARS-CoV-2 positive and negative individuals | Journal of internal medicine | 2022 | 272 | 124 | |||
| Comparison of prognostic scores for inpatients with COVID-19: a retrospective monocentric cohort study | BMJ open respiratory research | 2022 | 297 | 130 | |||
| Avancées récentes en médecine interne | Revue médicale suisse | 2022 | 208 | 134 | |||
| Dexamethasone exposure in normal-weight and obese hospitalized COVID-19 patients: An observational exploratory trial | Clinical and translational science | 2022 | 156 | 151 | |||
| Eight versus 28-point lung ultrasonography in moderate acute heart failure: a prospective comparative study | Internal and emergency medicine | 2022 | 294 | 193 | |||
| Impact of the Genotype and Phenotype of CYP3A and P-gp on the Apixaban and Rivaroxaban Exposure in a Real-World Setting | Journal of personalized medicine | 2022 | 225 | 354 | |||
| Therapeutic anticoagulation to prevent thrombosis, coagulopathy, and mortality in severe COVID-19: The Swiss COVID-HEP randomized clinical trial | Research and practice in thrombosis and haemostasis | 2022 | 250 | 284 | |||
| Outcomes with revascularization and medical therapy in patients with coronary disease and chronic kidney disease: A meta-analysis | Atherosclerosis | 2022 | 151 | 456 | |||
| Population Pharmacokinetic Models for Direct Oral Anticoagulants: A Systematic Review and Clinical Appraisal Using Exposure Simulation | Clinical pharmacology and therapeutics | 2022 | 165 | 279 | |||
| Development and assessment of PharmaCheck: an electronic screening tool for the prevention of twenty major adverse drug events | BMC medical informatics and decision making | 2022 | 289 | 341 | |||
| Confidence and use of physical examination and point-of-care ultrasonography for detection of abdominal or pleural free fluid. A cross-sectional survey | Internal and emergency medicine | 2022 | 224 | 215 | |||
| The pandemic toll and post-acute sequelae of SARS-CoV-2 in healthcare workers at a Swiss University Hospital | Preventive medicine reports | 2022 | 254 | 125 | |||
| Risk stratification for hospital-acquired venous thromboembolism in medical patients (RISE): Protocol for a prospective cohort study | PloS one | 2022 | 471 | 486 | |||
| Liquid Biopsy for Patient Characterization in Cardiovascular Disease: Verification against Markers of Cytochrome P450 and P-Glycoprotein Activities | Clinical pharmacology and therapeutics | 2022 | 180 | 384 | |||
| Kinetics of inflammatory biomarkers to predict one-year mortality in older patients hospitalized for pneumonia: a multivariable analysis | International journal of infectious diseases | 2022 | 214 | 238 | |||
| The chronification of post-COVID condition associated with neurocognitive symptoms, functional impairment and increased healthcare utilization | Scientific reports | 2022 | 221 | 114 | |||
| Impact of SARS-CoV-2 Infection (COVID-19) on Cytochromes P450 Activity Assessed by the Geneva Cocktail | Clinical pharmacology and therapeutics | 2021 | 212 | 236 | |||
| Prognosis of Laboratory-Confirmed Influenza and Respiratory Syncytial Virus in Acute Heart Failure | Journal of clinical medicine | 2021 | 232 | 109 | |||
| miR-204-5p and Platelet Function Regulation: Insight into a Mechanism Mediated by CDC42 and GPIIbIIIa | Thrombosis and haemostasis | 2021 | 102 | 103 | |||
| Model-Informed Precision Dosing: Background, Requirements, Validation, Implementation, and Forward Trajectory of Individualizing Drug Therapy | Annual Review of Pharmacology and Toxicology | 2021 | 456 | 1 | |||
| Drug-drug interactions with direct oral anticoagulants: practical recommendations for clinicians | The American journal of medicine | 2021 | 177 | 0 | |||
| Mixing Drugs and Genetics: A Complex Hemorrhagic Cocktail | American Journal of Medicine | 2021 | 286 | 5 | |||
| 2020 en revue par les internistes hospitaliers | Revue médicale suisse | 2021 | 237 | 295 | |||
| Electronic monitoring of potential adverse drug events related to lopinavir/ritonavir and hydroxychloroquine during the first wave of COVID-19 | European journal of hospital pharmacy | 2021 | 223 | 0 | |||
| An Ex Vivo and In Silico Study Providing Insights into the Interplay of Circulating miRNAs Level, Platelet Reactivity and Thrombin Generation: Looking beyond Traditional Pharmacogenetics | Journal of Personalized Medicine | 2021 | 251 | 260 | |||
| Role of Clinical Characteristics and Biomarkers at Admission to Predict One-Year Mortality in Elderly Patients with Pneumonia | Journal of clinical medicine | 2021 | 269 | 204 | |||
| Head-to-head evaluation of five automated SARS-CoV-2 serology immunoassays in various prevalence settings | Journal of Clinical Medicine | 2021 | 343 | 223 | |||
| Role of Intermediate Care Unit Admission and Noninvasive Respiratory Support during the COVID-19 Pandemic: A Retrospective Cohort Study | Respiration | 2021 | 226 | 291 | |||
| Accuracy of C-reactive protein, procalcitonin, serum amyloid A and neopterin for low-dose CT-scan confirmed pneumonia in elderly patients: A prospective cohort study | PLOS ONE | 2020 | 366 | 327 | |||
| Platelet function test use for patients with coronary artery disease in the early 2020s | Journal of clinical medicine | 2020 | 197 | 184 | |||
| Early experimental COVID-19 therapies: associations with length of hospital stay, mortality and related costs | Swiss Medical Weekly | 2020 | 508 | 461 | |||
| Genomewide Association Study of Platelet Reactivity and Cardiovascular Response in Patients Treated With Clopidogrel: A Study by the International Clopidogrel Pharmacogenomics Consortium | Clinical Pharmacology and Therapeutics | 2020 | 204 | 110 | |||
| Diagnostic accuracy of Augurix COVID-19 IgG serology rapid test | European Journal of Clinical Investigation | 2020 | 460 | 467 | |||
| MicroRNA-126 is a regulator of platelet-supported thrombin generation | Platelets | 2020 | 313 | 337 | |||
| The well-being of Swiss general internal medicine residents | Swiss Medical Weekly | 2020 | 362 | 276 | |||
| Head-to-head accuracy comparison of three commercial COVID-19 IgM/IgG serology rapid tests | Journal of Clinical Medicine | 2020 | 380 | 214 | |||
| Point of care ultrasonography from the emergency department to the internal medicine ward: current trends and perspectives | Internal and Emergency Medicine | 2020 | 315 | 2,032 | |||
| Guillain-Barré syndrome as a complication of SARS-CoV-2 infection | Brain, behavior, and immunity | 2020 | 267 | 148 | |||
| Functional Independence Measure score is associated with mortality in critically ill elderly patients admitted to an intermediate care unit | BMC Geriatrics | 2020 | 231 | 265 | |||
| Feasibility and safety of high-intensity interval training for the rehabilitation of geriatric inpatients (HIITERGY) a pilot randomized study | BMC Geriatrics | 2020 | 291 | 339 | |||
| Vegetarian, pescatarian and flexitarian diets: sociodemographic determinants and association with cardiovascular risk factors in a Swiss urban population | The British journal of nutrition | 2020 | 224 | 297 | |||
| Contribution of exome sequencing to the identification of genes involved in the response to clopidogrel in cardiovascular patients | Journal of Thrombosis and Haemostasis | 2020 | 292 | 1 | |||
| Methods to investigate miRNA function: focus on platelet reactivity | Thrombosis and Haemostasis | 2020 | 248 | 189 | |||
| A high glucose level is associated with decreased aspirin-mediated acetylation of platelet cyclooxygenase (COX)-1 at serine 529: A pilot study | Journal of Proteomics | 2019 | 528 | 535 | |||
| Functional validation of microRNA-126-3p as a platelet reactivity regulator using human haematopoietic stem cells | Thrombosis and Haemostasis | 2019 | 514 | 483 | |||
| Associations between early handoffs, length of stay and complications in internal medicine wards: A retrospective study | European journal of internal medicine | 2019 | 186 | 1 | |||
| Towards personalized antithrombotic treatments: focus on P2Y12 inhibitors and direct oral anticoagulants | Clinical Pharmacokinetics | 2019 | 504 | 2 | |||
| Médecine interne hospitalière en revue | Revue médicale suisse | 2019 | 265 | 166 | |||
| Anticoagulant therapy for acute venous thrombo-embolism in cancer patients: A systematic review and network meta-analysis | PLOS ONE | 2019 | 280 | 298 | |||
| Platelet Function Testing or Genotyping: Which Should We Trust? | JACC: Cardiovascular Interventions | 2019 | 220 | 0 | |||
| Accuracy of comprehensive PCR analysis of nasopharyngeal and oropharyngeal swabs for CT-scan-confirmed pneumonia in elderly patients: a prospective cohort study | Clinical Microbiology and Infection | 2019 | 447 | 222 | |||
| Impact of Boosted Antiretroviral Therapy on the Pharmacokinetics and Efficacy of Clopidogrel and Prasugrel Active Metabolites | Clinical Pharmacokinetics | 2018 | 738 | 863 | |||
| Complex Drug-Drug-Gene-Disease Interactions Involving Cytochromes P450: Systematic Review of Published Case Reports and Clinical Perspectives | Clinical Pharmacokinetics | 2018 | 523 | 1,015 | |||
| Genome-wide and candidate gene approaches of clopidogrel efficacy using pharmacodynamic and clinical end points-Rationale and design of the International Clopidogrel Pharmacogenomics Consortium (ICPC) | American Heart Journal | 2018 | 493 | 256 | |||
| Large bowel obstruction: a case of uncommon aetiology of a frequent condition | Age and Ageing | 2018 | 273 | 0 | |||
| Low-dose computed tomography for the diagnosis of pneumonia in elderly patients: a prospective, interventional cohort study | European Respiratory Journal | 2018 | 546 | 188 | |||
| Platelet reactivity in stable cardiovascular patients with chronic kidney disease | Platelets | 2018 | 527 | 0 | |||
| Functional Performances on Admission Predict In-Hospital Falls, Injurious Falls, and Fractures in Older Patients: A Prospective Study | Journal of Bone and Mineral Research | 2018 | 541 | 3 | |||
| Shotgun proteomics data on the impact of hyperglycaemia on platelet protein acetylation by aspirin | Data in Brief | 2018 | 493 | 210 | |||
| Diagnosis of systemic lupus erythematosus by presence of Hargraves cells in eosinophilic pleural effusion | Medicine (Baltimore) | 2018 | 240 | 166 | |||
| Pannexin1 Single Nucleotide Polymorphism and Platelet Reactivity in a Cohort of Cardiovascular Patients | Cell communication & adhesion | 2017 | 574 | 2 | |||
| Acute Appendicitis in Elderly Adults: A Difficult Diagnosis | Journal of the American Geriatrics Society | 2016 | 658 | 0 | |||
| Vascular risk levels affect the predictive value of platelet reactivity for the occurrence of MACE in patients on clopidogrel. Systematic review and meta-analysis of individual patient data | Thrombosis and haemostasis | 2016 | 579 | 269 | |||
| Genetics of clopidogrel poor-response | Antiplatelet Therapy in Cardiovascular Disease | 2016 | 517 | 0 | |||
| New molecular insights into modulation of platelet reactivity in aspirin-treated patients using a network-based approach | Human genetics | 2016 | 834 | 325 | |||
| Sepsis chez le sujet âgé : quelles spécificités ? | Revue médicale suisse | 2016 | 715 | 694 | |||
| PPM1A Methylation Is Associated With Vascular Recurrence in Aspirin-Treated Patients | Stroke | 2016 | 560 | 0 | |||
| Aspirin response: Differences in serum thromboxane B2 levels between clinical studies | Platelets | 2016 | 715 | 1 | |||
| Coadministration of ticagrelor and ritonavir: Toward prospective dose adjustment to maintain an optimal platelet inhibition using the PBPK approach | Clinical pharmacology and therapeutics | 2016 | 670 | 1,029 | |||
| Pharmacogenomics of Oral Antithrombotic Drugs | Current pharmaceutical design | 2016 | 625 | 0 | |||
| Simple comme un SMS ! | La Revue de médecine interne | 2016 | 514 | 146 | |||
| TRAF3 Epigenetic Regulation Is Associated With Vascular Recurrence in Patients With Ischemic Stroke | Stroke | 2016 | 528 | 0 | |||
| An unusual cause of bilateral lower extremity edema in an older woman | Journal of the American Geriatrics Society | 2015 | 568 | 2 | |||
| Antiplatelet drugs and platelet reactivity: is it time to halt clinical research on tailored strategies? | Expert opinion on pharmacotherapy | 2015 | 682 | 2 | |||
| Treatment of systemic necrotizing vasculitides in patients aged sixty-five years or older: results of a multicenter, open-label, randomized controlled trial of corticosteroid and cyclophosphamide-based induction therapy | Arthritis & rheumatology | 2015 | 603 | 0 | |||
| Impact of non-inhibited platelet supplementation on platelet reactivity in patients treated with prasugrel or ticagrelor for an acute coronary syndrome: An ex vivo study | Platelets | 2015 | 585 | 0 | |||
| Mon patient est trop âgé pour une statine : mythes et réalités | Revue médicale suisse | 2015 | 479 | 0 | |||
| Prothrombin G20210A mutation and lower extremity peripheral arterial disease: a systematic review and meta-analysis | European journal of vascular and endovascular surgery | 2015 | 590 | 287 | |||
| Suspicion of heparin-induced thrombocytopenia in internal medicine: How appropriate is the ordering of anti-PF4/heparin antibody testing? | Platelets | 2015 | 684 | 3 | |||
| A Case of Tuberculous Granulomatous Panniculitis without Vasculitis | Case reports in dermatology | 2015 | 634 | 309 | |||
| Pneumonie chez le sujet âgé : y a-t-il des spécificités ? | Revue médicale suisse | 2014 | 621 | 2 | |||
| Hémostase. Aspirine: une ou deux fois par jour? | Revue médicale suisse | 2014 | 585 | 0 | |||
| How to manage prasugrel and ticagrelor in daily practice | European journal of internal medicine | 2014 | 507 | 791 | |||
| Antiplatelet Therapy: Targeting the TxA2 Pathway | Journal of cardiovascular translational research | 2014 | 651 | 2 | |||
| Role of paraoxonase-1 in CYP2C19 loss-of-function carriers | Thrombosis research | 2014 | 674 | 0 | |||
| Characterization of the platelet granule proteome: Evidence of the presence of MHC1 in alpha-granules | Journal of proteomics | 2014 | 795 | 3 | |||
| Tailored Thienopyridine therapy: no urgency for CYP2C19 genotyping | Journal of the American Heart Association. Cardiovascular and cerebrovascular disease | 2013 | 594 | 0 | |||
| Antiplaquettaires et patients âgés : quelles molécules et quelles preuves ? | Revue médicale suisse | 2013 | 587 | 0 | |||
| Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding | Journal of the American College of Cardiology | 2013 | 535 | 1,136 | |||
| Unraveling modulators of platelet reactivity incardiovascular patients using omics strategies: Towards anetwork biology paradigm | Translational proteomics | 2013 | 660 | 601 | |||
| Antiplatelet drug response status does not predict recurrent ischemic events in stable cardiovascular patients: results of the Antiplatelet Drug Resistances and Ischemic Events study | Circulation | 2012 | 737 | 94 | |||
| Intramural hematoma of the esophagus | Case reports in gastroenterology | 2012 | 543 | 0 | |||
| Application pratique et intérêt des recommandations de prise en charge des syncopes : évaluation de pratiques professionnelles | Annales de cardiologie et d'angéiologie | 2012 | 571 | 0 | |||
| Prevalence of poor biological response to clopidogrel: a systematic review | Thrombosis and haemostasis | 2012 | 553 | 0 | |||
| Poor responsiveness to antiplatelet drugs in acute coronary syndromes: clinical relevance and management | Cardiovascular therapeutics | 2012 | 634 | 0 | |||
| Nutrition entérale : sonde nasogastrique ou gastrostomie percutanée endoscopique? | Revue médicale suisse | 2012 | 646 | 2 | |||
| Influence of the paraoxonase-1 Q192R genetic variant on clopidogrel responsiveness and recurrent cardiovascular events: a systematic review and meta-analysis | Journal of thrombosis and haemostasis | 2012 | 622 | 0 | |||
| Severe mitral valve regurgitation in polymyositis | Journal of clinical rheumatology | 2012 | 565 | 0 | |||
| The paraoxonase-1 pathway is not a major bioactivation pathway of clopidogrel in vitro | British journal of pharmacology | 2012 | 592 | 0 | |||
| Thrombose coronaire distale compliquant une leucémie aiguë lymphoblastique traitée par asparaginase | Annales de cardiologie et d'angéiologie | 2012 | 706 | 584 | |||
| Platelet proteomics | Mass spectrometry reviews | 2012 | 547 | 2 | |||
| Relationship between paraoxonase-1 activity, its Q192R genetic variant and clopidogrel responsiveness in the ADRIE study | Journal of thrombosis and haemostasis | 2011 | 638 | 0 | |||
| Une histoire pas très originale dans un contexte pas très confortable...Hemoptysis in a 55-year-old man | La Revue de médecine interne | 2011 | 634 | 0 | |||
| Platelet reactivity is a stable and global phenomenon in aspirin-treated cardiovascular patients | Thrombosis and haemostasis | 2011 | 653 | 0 | |||
| Anémie ferriprive, inflammatoire ou mixte: comment orienter le diagnostic? | Revue médicale suisse | 2011 | 1,319 | 5 | |||
| Médecine interne hospitalière : l'année 2010 en revue (1) | Revue médicale suisse | 2011 | 972 | 0 | |||
| Clinical implications of clopidogrel non-response in cardiovascular patients: a systematic review and meta-analysis | Journal of thrombosis and haemostasis | 2010 | 584 | 0 | |||
| Maladies cardiovasculaires, antiagrégants, anticoagulants et risque hémorragique | Revue médicale suisse | 2010 | 608 | 0 | |||
| Médecine interne hospitalière : l'année 2009 en revue (2) | Revue médicale suisse | 2010 | 595 | 1 | |||
| Evaluation de l'efficacité biologique du clopidogrel: génotype ou phénotype? | Revue médicale suisse | 2010 | 521 | 0 | |||
| Antiagregants plaquettaires : lequel, quand et pour qui ? | La Revue de médecine interne | 2010 | 511 | 0 | |||
| Clinical predictors of dual aspirin and clopidogrel poor responsiveness in stable cardiovascular patients from the ADRIE study | Journal of thrombosis and haemostasis | 2010 | 607 | 0 | |||
| Acute coronary syndrome and its antithrombotic treatment: focus on aspirin and clopidogrel resistance | Current vascular pharmacology | 2009 | 532 | 0 | |||
| Le concept de "resistance" a l'aspirine: mecanismes et pertinence clinique | La Revue de médecine interne | 2009 | 563 | 0 | |||
| Platelet hyperreactivity and dual antiplatelet therapy: can biases be avoided? | Journal of thrombosis and haemostasis | 2009 | 525 | 0 | |||
| Use of the PFA-100 closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: a systematic review and meta-analysis | Journal of thrombosis and haemostasis | 2008 | 663 | 0 | |||
| Laboratory-defined aspirin resistance and recurrent cardiovascular events | Archives of internal medicine | 2008 | 581 | 0 | |||
| Aspirin "resistance" and risk of cardiovascular morbidity | BMJ. British medical journal | 2008 | 538 | 1 | |||
| Aspirin response variability assessed with the PFA-100 device | Thrombosis and haemostasis | 2008 | 609 | 0 | |||
| Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects | Circulation | 2003 | 340 | 209 |
